161 related articles for article (PubMed ID: 20621652)
1. Advances in management of bone disease in breast cancer.
Walkington L; Coleman RE
Bone; 2011 Jan; 48(1):80-7. PubMed ID: 20621652
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?
Freedman OC; Amir E; Clemons MJ
Crit Rev Oncol Hematol; 2009 Oct; 72(1):56-64. PubMed ID: 19307138
[TBL] [Abstract][Full Text] [Related]
3. Management of bisphosphonate treatment in clinical practice.
Aapro MS
Semin Oncol; 2007 Dec; 34(6 Suppl 4):S28-32. PubMed ID: 18068488
[TBL] [Abstract][Full Text] [Related]
4. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
Lipton A
Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy.
Saad F; Sternberg CN
Nat Clin Pract Urol; 2007 Feb; 4 Suppl 1():S3-13. PubMed ID: 17264863
[TBL] [Abstract][Full Text] [Related]
6. The evolving role of bone-conserving therapy in patients with breast cancer.
Brufsky AM
Semin Oncol; 2010 Jun; 37 Suppl 1():S12-9. PubMed ID: 20682367
[TBL] [Abstract][Full Text] [Related]
7. New results from the use of bisphosphonates in cancer patients.
Coleman R; Gnant M
Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
[TBL] [Abstract][Full Text] [Related]
8. [Bisphosphonates and breast cancer].
Vehmanen L; Saarto T
Duodecim; 2010; 126(10):1229-37. PubMed ID: 20597352
[TBL] [Abstract][Full Text] [Related]
9. The use of bisphosphonates in cancer treatment.
Coleman R
Ann N Y Acad Sci; 2011 Feb; 1218():3-14. PubMed ID: 20946581
[TBL] [Abstract][Full Text] [Related]
10. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L
Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
[TBL] [Abstract][Full Text] [Related]
11. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
Candelaria-Quintana D; Dayao ZR; Royce ME
Breast Cancer Res Treat; 2012 Apr; 132(2):355-63. PubMed ID: 21987034
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of bone metastases in breast cancer patients.
Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
[TBL] [Abstract][Full Text] [Related]
13. [Current use of bisphosphonates in clinical oncology].
Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of bisphosphonates in cancer therapy.
Lüftner D; Henschke P; Possinger K
Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
[TBL] [Abstract][Full Text] [Related]
15. The role of bisphosphonates in early breast cancer.
Paterson AH
Oncologist; 2006; 11 Suppl 1():13-9. PubMed ID: 16971735
[TBL] [Abstract][Full Text] [Related]
16. Reducing the risk of cancer treatment-associated bone loss in patients with breast cancer.
Hadji P; Bundred N
Semin Oncol; 2007 Dec; 34(6 Suppl 4):S4-10. PubMed ID: 18068489
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefits and considerations of bisphosphonate treatment in metastatic bone disease.
Saad F; Lipton A
Semin Oncol; 2007 Dec; 34(6 Suppl 4):S17-23. PubMed ID: 18068486
[TBL] [Abstract][Full Text] [Related]
18. Bone continuum of cancer.
Lipton A
Am J Clin Oncol; 2010 Jun; 33(3 Suppl):S1-7. PubMed ID: 20526089
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate therapy for patients with breast carcinoma.
Plunkett TA; Rubens RD
Cancer; 2003 Feb; 97(3 Suppl):854-8. PubMed ID: 12548586
[TBL] [Abstract][Full Text] [Related]
20. The use of bisphosphonates in cancer patients.
Wu S; Dahut WL; Gulley JL
Acta Oncol; 2007; 46(5):581-91. PubMed ID: 17562434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
